These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 17654873)

  • 21. [Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative].
    Själander A; Wallentin L; Rosenqvist M; Svensson P
    Lakartidningen; 2008 Sep 10-16; 105(37):2478-80. PubMed ID: 19006862
    [No Abstract]   [Full Text] [Related]  

  • 22. Anti-thrombotic therapy for atrial fibrillation and patients' preferences for treatment.
    Lane D; Lip GY
    Age Ageing; 2005 Jan; 34(1):1-3. PubMed ID: 15591476
    [No Abstract]   [Full Text] [Related]  

  • 23. Stroke risk in atrial fibrillation patients on warfarin. Predictive ability of risk stratification schemes for primary and secondary prevention.
    Poli D; Antonucci E; Grifoni E; Abbate R; Gensini GF; Prisco D
    Thromb Haemost; 2009 Feb; 101(2):367-72. PubMed ID: 19190823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.
    Hylek EM
    Thromb Haemost; 2008 Jul; 100(1):16-7. PubMed ID: 18612532
    [No Abstract]   [Full Text] [Related]  

  • 25. Risk factors and stroke risk stratification for atrial fibrillation: limitations and new possibilities.
    Lip GY
    Am Heart J; 2008 Jul; 156(1):1-3. PubMed ID: 18585489
    [No Abstract]   [Full Text] [Related]  

  • 26. The need for new oral anticoagulants in clinical practice.
    Hylek EM
    J Cardiovasc Med (Hagerstown); 2009 Aug; 10(8):605-9. PubMed ID: 19571764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multicenter randomized study of anticoagulation guided by remote rhythm monitoring in patients with implantable cardioverter-defibrillator and CRT-D devices: Rationale, design, and clinical characteristics of the initially enrolled cohort The IMPACT study.
    Ip J; Waldo AL; Lip GY; Rothwell PM; Martin DT; Bersohn MM; Choucair WK; Akar JG; Wathen MS; Rohani P; Halperin JL;
    Am Heart J; 2009 Sep; 158(3):364-370.e1. PubMed ID: 19699858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atrial fibrillation--rate versus rhythm control.
    Manning WJ
    N Engl J Med; 2003 Mar; 348(13):1284-6; author reply 1284-6. PubMed ID: 12661569
    [No Abstract]   [Full Text] [Related]  

  • 29. Identifying AF patients at risk of stroke: can prothrombotic indices improve things?
    Watson T; Lip GY
    Int J Cardiol; 2008 Jun; 126(3):299-301. PubMed ID: 18077017
    [No Abstract]   [Full Text] [Related]  

  • 30. Anticoagulation: stroke prevention in patients with atrial fibrillation.
    Waldo AL
    Cardiol Clin; 2009 Feb; 27(1):125-35, ix. PubMed ID: 19111769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of warfarin: trial versus "real-world" stroke prevention in atrial fibrillation.
    Sorensen SV; Dewilde S; Singer DE; Goldhaber SZ; Monz BU; Plumb JM
    Am Heart J; 2009 Jun; 157(6):1064-73. PubMed ID: 19464418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reducing the risk for stroke in patients who have atrial fibrillation.
    Garcia DA; Hylek E
    Cardiol Clin; 2008 May; 26(2):267-75, vii. PubMed ID: 18406999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation?
    Nieuwlaat R; Dinh T; Olsson SB; Camm AJ; Capucci A; Tieleman RG; Lip GY; Crijns HJ;
    Eur Heart J; 2008 Apr; 29(7):915-22. PubMed ID: 18334476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Closing in on ending the warfarin era for stroke prevention in nonvalvular atrial fibrillation.
    Turi ZG
    Catheter Cardiovasc Interv; 2009 Aug; 74(2):223-4. PubMed ID: 19642149
    [No Abstract]   [Full Text] [Related]  

  • 35. Stroke prophylaxis in patients with atrial fibrillation: what can we do about it?
    Naunton M
    Eur Heart J; 2007 May; 28(9):1172-3; author reply 1173. PubMed ID: 17446229
    [No Abstract]   [Full Text] [Related]  

  • 36. Stroke event rates in anticoagulated patients with paroxysmal atrial fibrillation.
    Lip GY; Frison L; Grind M;
    J Intern Med; 2008 Jul; 264(1):50-61. PubMed ID: 18266660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy.
    Hohnloser SH; Pajitnev D; Pogue J; Healey JS; Pfeffer MA; Yusuf S; Connolly SJ;
    J Am Coll Cardiol; 2007 Nov; 50(22):2156-61. PubMed ID: 18036454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of atrial fibrillation in the elderly.
    Aronow WS
    Minerva Med; 2009 Feb; 100(1):3-24. PubMed ID: 19182738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anticoagulation: stroke prevention in patients with atrial fibrillation.
    Waldo AL
    Med Clin North Am; 2008 Jan; 92(1):143-59, xi. PubMed ID: 18061002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stroke in atrial fibrillation: update on pathophysiology, new antithrombotic therapies, and evolution of procedures and devices.
    Savelieva I; Bajpai A; Camm AJ
    Ann Med; 2007; 39(5):371-91. PubMed ID: 17701479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.